Citation:Amin, M.B., Edge, S., Greene, F., Byrd, D.R., Brookland, R.K., Washington, M.K., Gershenwald, J.E., Compton, C.C., Hess, K.R., Sullivan, D.C., Jessup, J.M., Brierley, J.D., Gaspar, L.E., Schilsky, R.L., Balch, C.M., 2017
From Cancer Guidelines Wiki
Citation
Amin MB, Edge S, Greene F, Byrd DR, Brookland RK, Washington MK, Gershenwald JE, Compton CC, Hess KR, et al. (Eds.). AJCC Cancer Staging Manual (8th edition). Springer International Publishing: American Joint Commission on Cancer; 2017 [cited 2016 Dec 28].
Critical appraisals
Compare quality appraisals for each clinical question
Cited by
- 12.2 Systemic therapies for metastatic cutaneous squamous cell carcinoma
- 5.4 Pathology of rare tumours
- 6.1 Prognosis of basal cell carcinoma
- 6.2 Prognosis of cutaneous squamous cell carcinoma
- 7.1 Considerations before selecting a surgical treatment modality
- 7.5 Post-surgical care and interpretation of the pathology report
- 8.1 Radiotherapy with or without surgical treatment for keratinocyte cancer
- 8.2 Radiotherapy for basal cell carcinoma
- 8.3 Radiotherapy for cutaneous squamous cell carcinoma
- 8.4 Radiotherapy for regional (nodal) metastatic disease (non-distant)
- 8.5 Radiotherapy for actinic keratosis and cutaneous squamous cell carcinoma in situ
- Development of post-surgical staging
- Glossary and abbreviations
- Introduction
- Neoadjuvant therapy for rectal cancer
- Notable differences between available clinicopathological staging systems